US EditionPublished • loading... • Updated
J&J reports positive data for Erda-iDRS in bladder cancer
Summary by Clinical Trials Arena
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
J&J reports positive data for Erda-iDRS in bladder cancer
J&J has reported encouraging results from a Phase I study of the investigational intravesical drug-releasing system, Erda-iDRS, in patients with intermediate- and high-risk NMIBC harbouring select FGFR alterations.The post J&J reports positive data for Erda-iDRS in bladder cancer appeared first on Clinical Trials Arena.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
